What is KaryoTrack?
KaryoTrack is an advanced chromosomal analysis test designed to detect numerical and structural abnormalities in chromosomes. Utilising high-resolution genomic technology, it identifies aneuploidies, deletions, duplications, and translocations, making it essential for diagnosing genetic disorders, recurrent pregnancy loss, infertility, and congenital anomalies. The test is particularly valuable in prenatal screening, fertility assessments, and genetic counselling. KaryoTrack provides rapid, high-precision results, aiding clinicians in making informed medical and reproductive decisions for personalised patient care.
KaryoTrack offers broad clinical coverage across multiple disease areas, including neurological, oncological, cardiovascular, endocrine and metabolic, haematological, and newborn conditions, among others. It is cost-effective, suitable for both prenatal and postnatal samples, and detects 700K genome-wide probes, including CNVs, ROHs, mosaicism, UPD, and polyploidy.